🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: BI 100 mg (fasted)

Found 10 matching trials

To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers

PHASE1

The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...

Status

Completed

Location

Humanpharmakologisches Zentrum Biberach

Start Date

2017-01-12

Trial ID

NCT03004404

Treatments Being Tested

Placebo BI 730357 BI 730357

Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers

PHASE1

The objective of this trial was to evaluate the relative oral bioavailabili...

Status

Completed

Location

Multiple Locations

Start Date

2008-01

Trial ID

NCT02215746

Treatments Being Tested

BI 44370 powder for oral solution BI 44370 tablet high fat breakfast

A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

PHASE1

To investigate the relative bioavailability of the intended Commercial Form...

Status

Completed

Location

Humanpharmakologisches Zentrum Biberach

Start Date

2022-01-14

Trial ID

NCT05155306

Treatments Being Tested

BI 1358894, intended Commercial Formulation (iCF) (T)BI 1358894, Trial Formulation 2 (TFII) (R)

Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers

PHASE1

To compare the oral bioavailability and rate of absorption of two different...

Status

Completed

Location

Multiple Locations

Start Date

2010-02

Trial ID

NCT02221388

Treatments Being Tested

BI 671800 HEA, 200 mg tablets BI 671800 HEA EC, 200 mg tablets BI 671800 HEA, 50 mg tablets BI 671800 ED, 100 mg capsules Standard meal

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

PHASE2

To assess long-term safety, tolerability, and efficacy of BI 730357 in pati...

Status

Terminated

Location

Total Skin and Beauty Dermatology Center, PC

Start Date

2019-03-18

Trial ID

NCT03835481

Treatments Being Tested

BI 730357 Placebo to match BI 730357

Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers

PHASE1

Evaluation of safety, tolerability and PK of single rising oral doses of BI...

Status

Completed

Location

Multiple Locations

Start Date

2008-03

Trial ID

NCT02259842

Treatments Being Tested

BI 34021 FU2 solution BI 34021 FU2 tablet Placebo High fat, high calorie breakfast

A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood

PHASE1

The main objective of this trial is to investigate the relative bioavailabi...

Status

Completed

Location

CRS Clinical Research Services Mannheim GmbH

Start Date

2019-04-08

Trial ID

NCT03892616

Treatments Being Tested

BI 1358894 (B)BI 1358894 (C)BI 1358894 (D)BI 1358894 (E)BI 1358894 (A)

This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is

PHASE2

The primary objective is based on Week 12 co-primary endpoints of PASI (Pso...

Status

Completed

Location

Total Skin and Beauty Dermatology Center, PC

Start Date

2018-09-17

Trial ID

NCT03635099

Treatments Being Tested

Placebo (fasted)BI 25 mg (fasted)BI 50 mg (fasted)BI 100 mg (fasted)BI 200 mg (fasted)Placebo (fed)BI 400 mg once daily (fed)BI 200 mg twice daily, 400 mg total (fed)

A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood

PHASE1

The main objectives of this trial are to investigate safety, tolerability a...

Status

Completed

Location

SGS Life Science Services - Clinical Research

Start Date

2019-01-30

Trial ID

NCT03794323

Treatments Being Tested

BI 764122 Placebo

A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood

PHASE1

The main objective of the single-rising dose (SRD) part and the multiple ri...

Status

Completed

Location

SOUSEIKAI Sumida Hospital

Start Date

2020-11-13

Trial ID

NCT04619251

Treatments Being Tested

BI 1323495 Placebo Itraconazole

Previous Next